Big movements in Immuneering Corporation stock price on Thursday moving 13.44% between high and low
(Updated on Dec 01, 2022)
The Immuneering Corporation stock price gained 2.83% on the last trading day (Thursday, 1st Dec 2022), rising from $6.53 to $6.72. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 13.44% from a day low at $6.25 to a day high of $7.09. The price has risen in 7 of the last 10 days and is up by 0.98% over the past 2 weeks. Volume fell on the last day by -19 thousand shares and in total, 20 thousand shares were bought and sold for approximately $131.72 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
Here's how to open broker account if you're new to investing.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -25.79% during the next 3 months and, with a 90% probability hold a price between $2.38 and $9.05 at the end of this 3-month period.
IMRX Signals & Forecast
There are mixed signals in the stock today. The Immuneering Corporation stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term moving average at $10.06. On a fall, the stock will find some support from the short-term average at $6.53. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Tuesday, October 04, 2022, and so far it has fallen -55.23%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Immuneering Corporation stock
Immuneering Corporation finds support from accumulated volume at $6.70 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.84 between high and low, or 13.44%. For the last week the stock has had daily average volatility of 8.89%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (IMRX) For The Upcoming Trading Day Of Friday 2nd
For the upcoming trading day on Friday, 2nd we expect Immuneering Corporation to open at $6.69, and during the day (based on 14 day Average True Range), to move between $5.81 and $7.62, which gives a possible trading interval of +/-$0.90 (+/-13.45%) up or down from last closing price. If Immuneering Corporation takes out the full calculated possible swing range there will be an estimated 26.90% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $6.70 (0.22%) than the resistance at $7.36 (9.61%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Immuneering Corporation stock A Buy?
Immuneering Corporation holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score: -4.851 Open Broker AccountSell Candidate Unchanged
Predicted Opening Price for Immuneering Corporation of Friday, December 2, 2022
The predicted opening price is based on yesterday's movements between high, low, and closing price.
|Fair opening price December 2, 2022||Current price|
Remember To Visit Our YouTube Channel
Fibonacci Support & Resistance Levels
Accumulated Volume Support & Resistance Levels
Click to get the best stock tips daily for free!
About Immuneering Corporation
Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to treat solid tumors. The company also has five oncology programs in the discovery stage that are designed ... IMRX Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.